tradingkey.logo
tradingkey.logo
Search

Solid Biosciences Inc

SLDB
Add to Watchlist
7.480USD
-0.540-6.73%
Close 09-24 16:00(ET)
736.41MMarket Cap
LossP/E TTM

SLDB Financials

See Solid Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
736.41M
Dividend TTM
0.00
P/E TTM
-3.91
EPS TTM
-1.92
Revenue
--
Net Profit
-124.70M
ROE
-57.37%
ROA
-50.02%

Solid Biosciences Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.38/-0.47
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
9.06%-0.38
12.74%-0.52
47.34%-0.53
38.60%-0.48
31.53%-0.42
7.04%-0.59
0.79%-1.00
24.50%-0.79
51.10%-0.61
58.55%-0.64
23.82%-1.01
---1.05
---1.25
---1.54
---1.32
---141.30
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
71.65%6.17M
-42.28%1.93M
--3.15M
--3.54M
Net Profit
-38.80%-54.80M
-44.44%-56.74M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-109.47%-42.60M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.30M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
-49.87%-25.33M
12.89%-18.61M
15.36%-17.98M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---875.09%
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
Debt to assets ratio
----
----
-100.00%0.00%
-84.00%0.10%
-78.86%0.31%
-50.34%0.32%
-36.80%0.65%
-34.39%0.64%
57.49%1.46%
-26.03%0.64%
13.33%1.03%
--0.98%
--0.93%
--0.87%
--0.91%
--0.19%
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
71.65%6.17M
-42.28%1.93M
--3.15M
--3.54M
Operating profit
-37.63%-57.38M
-43.08%-57.31M
-23.83%-49.40M
-36.60%-48.06M
-50.04%-41.69M
-49.10%-40.05M
-79.19%-39.90M
-52.21%-35.18M
-3.28%-27.79M
15.14%-26.86M
22.98%-22.27M
-9.38%-23.11M
-12.76%-26.91M
-24.77%-31.66M
-54.99%-28.91M
-17.20%-21.13M
-27.71%-23.86M
-50.25%-25.37M
12.62%-18.65M
15.05%-18.03M
Net Profit
-38.80%-54.80M
-44.44%-56.74M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-109.47%-42.60M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.30M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
-49.87%-25.33M
12.89%-18.61M
15.36%-17.98M
Current assets
41.80%395.11M
26.60%396.79M
30.61%205.46M
36.41%244.85M
41.01%278.64M
46.32%313.41M
21.25%157.30M
21.00%179.49M
17.99%197.61M
12.38%214.19M
-40.93%129.73M
0.57%148.35M
-1.74%167.47M
-4.03%190.60M
-1.34%219.64M
-38.23%147.51M
-33.18%170.44M
-27.59%198.61M
40.09%222.61M
779.21%238.81M
Total current liabilities
-4.23%28.58M
5.23%30.28M
10.63%33.47M
59.02%36.34M
103.20%29.85M
100.70%28.78M
108.42%30.26M
44.50%22.85M
-7.42%14.69M
-29.34%14.34M
-35.50%14.52M
-6.55%15.82M
-26.95%15.87M
-6.67%20.29M
-4.63%22.51M
-24.92%16.93M
-3.67%21.72M
-4.75%21.74M
-3.59%23.60M
52.67%22.54M
Total assets
36.42%420.58M
22.97%422.89M
23.26%232.54M
29.31%273.91M
33.47%308.29M
38.29%343.90M
14.38%188.66M
14.67%211.83M
12.83%230.98M
8.32%248.69M
-36.62%164.94M
0.14%184.73M
-1.81%204.72M
10.61%229.59M
11.99%260.25M
-25.91%184.47M
-21.58%208.50M
-27.24%207.56M
35.76%232.38M
514.51%248.99M
Total liabilities
-6.99%46.51M
-1.38%48.76M
2.17%52.53M
24.91%55.97M
32.50%50.00M
30.23%49.44M
33.69%51.42M
10.99%44.80M
-7.95%37.74M
-17.11%37.97M
-20.85%38.46M
-2.02%40.37M
-11.39%40.99M
107.76%45.80M
101.03%48.59M
60.79%41.20M
65.70%46.26M
-31.70%22.05M
-38.16%24.17M
40.12%25.62M
Total equity
44.83%374.07M
27.06%374.13M
31.16%180.01M
30.49%217.95M
33.66%258.29M
39.74%294.46M
8.51%137.25M
15.70%167.02M
18.03%193.25M
14.66%210.72M
-40.25%126.48M
0.76%144.36M
0.92%163.73M
-0.93%183.79M
1.66%211.67M
-35.86%143.28M
-31.82%162.24M
-26.68%185.51M
57.63%208.21M
904.74%223.36M
Net operating income
-40.56%-52.59M
-48.29%-47.23M
-80.65%-53.55M
-41.18%-33.47M
-74.28%-37.41M
-26.43%-31.85M
-42.37%-29.64M
-32.47%-23.71M
21.84%-21.47M
10.01%-25.19M
39.61%-20.82M
12.39%-17.90M
-72.98%-27.46M
-2.96%-28.00M
-65.18%-34.48M
-10.88%-20.43M
7.15%-15.88M
-27.26%-27.19M
-1697.09%-20.87M
-18.38%-18.42M
Net investment
-308.13%-133.59M
262.98%44.76M
21.90%47.01M
-312.06%-45.27M
-532.38%-32.73M
28.65%-27.46M
-14.86%38.57M
55.40%-10.99M
89.27%-5.18M
-203.30%-38.49M
-31.47%45.30M
-265.24%-24.64M
19.07%-48.23M
-1.28%37.26M
119.05%66.10M
120.56%14.91M
-22.33%-59.59M
107937.14%37.74M
50393.33%30.18M
-90537.50%-72.51M
Net financing
3127.55%48.47M
25.98%239.03M
-25.89%5.14M
-63.88%1.18M
-132.02%-1.60M
76.92%189.73M
1274.26%6.94M
--3.26M
91.06%5.00M
--107.24M
-99.32%505.00K
100.00%0.00
3484.93%2.62M
-100.00%0.00
113137.88%74.74M
-133.33%-1.00K
130.67%73.00K
-99.98%22.00K
-99.95%66.00K
--3.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its current assets were 205.46M, with a year-on-year change of 30.61.

What are the total assets of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its total assets of Solid Biosciences Inc were 232.54M, with a year-on-year change of 23.26.

What are the total liabilities of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its total liabilities of Solid Biosciences Inc were 52.53M, with a year-on-year change of 2.17.

What is the total equity of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its total equity of Solid Biosciences Inc was 180.01M, with a year-on-year change of 31.16.

What is the net operating income of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its net operating income of Solid Biosciences Inc was -179.21M, with a year-on-year change of -38.14.

What is the net investment of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its net investment of Solid Biosciences Inc was -58.45M, with a year-on-year change of -263.38.

What is the net financing of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its net financing of Solid Biosciences Inc was 194.45M, with a year-on-year change of 58.81.

What is the Earnings Per Share (EPS) of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.99, with a year-on-year change of 34.79.

What is the net income of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its net income was -174.32M, with a year-on-year change of -39.80.

What is the Return on Equity (ROE) of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -109.90, with a year-on-year change of -16.21.

What is the Return on Assets (ROA) of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -82.78, with a year-on-year change of -17.36.

What is the operating profit of Solid Biosciences Inc?

According to Solid Biosciences Inc's FY2025 earnings report, its operating profit was -179.21M, with a year-on-year change of -38.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.